Yifei Wu
University of Georgia
H-index: 10
North America-United States
Top articles of Yifei Wu
Nicardipine is a putative EED inhibitor and has high selectivity and potency against chemoresistant prostate cancer in preclinical models
British Journal of Cancer
2023/9/21
Structural and spectroscopic characterization of RufO indicates a new biological role in rufomycin biosynthesis
Journal of Biological Chemistry
2023/8/1
A novel Skp1 inhibitor has potent preclinical efficacy against metastatic castration-resistant prostate cancer
Cancer Research
2023/4/4
Identifying Drug Candidates for COVID-19 with Large-Scale Drug Screening
International journal of molecular sciences
2023/2/23
Yifei Wu
H-Index: 5
David Crich
H-Index: 38
Exploring and engineering PAM-diverse Streptococci Cas9 for PAM-directed bifunctional and titratable gene control in bacteria
Metabolic Engineering
2023/1/1
Repositioning nicardipine as a novel targeted therapy for chemoresistant prostate cancer
Cancer Research
2022/6/15
Polyphenols as potential inhibitors of SARS-CoV-2 RNA dependent RNA polymerase (RdRp)
Molecules
2021/12/8
Yifei Wu
H-Index: 5
David Crich
H-Index: 38
Engineering a PAM-flexible SpdCas9 variant as a universal gene repressor
Nature communications
2021/11/25
Polyphenols as Alternative Treatments of COVID-19
Computational and Structural Biotechnology Journal
2021/9
Yifei Wu
H-Index: 5
David Crich
H-Index: 38
Elucidating the inhibitory effect of resveratrol and its structural analogs on selected nucleotide-related enzymes
Biomolecules
2020/8/22
Yifei Wu
H-Index: 5
Xiaoxiao Wang
H-Index: 6
A pilot study of all-computational drug design protocol–from structure prediction to interaction analysis
Frontiers in Chemistry
2020/2/12
Yifei Wu
H-Index: 5
In silico identification of drug candidates against COVID-19
Informatics in Medicine Unlocked
2020/1/1
Yifei Wu
H-Index: 5
Co-Authors
